26.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$25.67
Aprire:
$25.56
Volume 24 ore:
1.40M
Relative Volume:
1.47
Capitalizzazione di mercato:
$1.24B
Reddito:
$203.27M
Utile/perdita netta:
$-4.66M
Rapporto P/E:
-268.70
EPS:
-0.1
Flusso di cassa netto:
$3.47M
1 W Prestazione:
+14.10%
1M Prestazione:
+53.63%
6M Prestazione:
+135.81%
1 anno Prestazione:
+105.11%
Axogen Inc Stock (AXGN) Company Profile
Nome
Axogen Inc
Settore
Industria
Telefono
(386) 462-6817
Indirizzo
13631 PROGRESS BLVD., ALACHUA, FL
Confronta AXGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
AXGN
Axogen Inc
|
26.87 | 1.18B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-17 | Iniziato | Lake Street | Buy |
| 2024-07-01 | Iniziato | Raymond James | Outperform |
| 2022-11-11 | Ripresa | Jefferies | Buy |
| 2022-05-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | Guggenheim | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Iniziato | Canaccord Genuity | Buy |
| 2018-03-02 | Reiterato | Lake Street | Buy |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Iniziato | Jefferies | Buy |
| 2017-11-21 | Reiterato | Lake Street | Buy |
| 2017-07-31 | Iniziato | Leerink Partners | Outperform |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Iniziato | ROTH Capital | Buy |
| 2016-11-22 | Aggiornamento | Lake Street | Hold → Buy |
| 2016-11-07 | Reiterato | Wedbush | Outperform |
| 2016-11-03 | Downgrade | Lake Street | Buy → Hold |
| 2016-08-04 | Reiterato | Wedbush | Outperform |
| 2014-05-14 | Iniziato | Dawson James | Buy |
| 2013-10-31 | Reiterato | Ladenburg Thalmann | Buy |
Mostra tutto
Axogen Inc Borsa (AXGN) Ultime notizie
Is SK International Export Limited a Hybrid Growth Value Stock Worth HoldingPrice-to-Book Ratio Updates & Free Tools to Monitor Market Corrections - earlytimes.in
First Week of July 2026 Options Trading For Axogen (AXGN) - Nasdaq
Is Axogen Inc. stock positioned for long term growth2025 Trading Volume Trends & AI Driven Stock Price Forecasts - newser.com
What analyst consensus says on Axogen Inc. stock2025 Volatility Report & Weekly High Momentum Picks - newser.com
How Axogen Inc. stock performs in weak economy2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Is Axogen Inc. stock attractive after correction2025 Investor Takeaways & High Accuracy Swing Entry Alerts - newser.com
Can Axogen Inc. stock sustain institutional interest2025 Price Momentum & Short-Term Trading Alerts - newser.com
Axogen stock reaches 52-week high at 24.94 USD By Investing.com - Investing.com Nigeria
Axogen stock reaches 52-week high at 24.94 USD - Investing.com
Will Axogen Inc. stock deliver strong dividend growthJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Does Axogen Inc. show high probability of reboundSell Signal & Safe Entry Point Identification - newser.com
How risky is Axogen Inc. stock nowPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
How supply chain issues affect Axogen Inc. stockJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Axogen at Jefferies Conference: Strategic Growth in Nerve Repair By Investing.com - Investing.com Australia
Axogen at Jefferies Conference: Strategic Growth in Nerve Repair - Investing.com
Axogen (AXGN) Price Target Increased by 15.18% to 29.24 - Nasdaq
Technical analysis overview for Axogen Inc. stockWeekly Risk Report & Community Consensus Picks - newser.com
Is Axogen Inc. stock a buy for dividend growthPortfolio Gains Report & High Win Rate Trade Alerts - newser.com
Will Axogen Inc. stock gain from government policiesJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
What’s next for Axogen Inc. stock priceJuly 2025 Outlook & Weekly Return Optimization Alerts - newser.com
Is Axogen Inc. stock ready for a breakout2025 Fundamental Recap & High Accuracy Swing Trade Signals - newser.com
Why Axogen Inc. stock is a must watch in 2025Weekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Multi factor analysis applied to Axogen Inc.2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
Is Axogen Inc. stock a buy in volatile markets2025 AllTime Highs & Real-Time Chart Pattern Alerts - Fundação Cultural do Pará
Axogen Director William P. Burke Sells 22,818 Shares - TradingView
[Form 4] Axogen, Inc. Insider Trading Activity - Stock Titan
Volatility clustering patterns for Axogen Inc.2025 Momentum Check & Daily Price Action Insights - newser.com
Axogen Inc Azioni (AXGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):